このセクションでは通常、投資家が会社の利益創出能力を理解する一助となるよう、プロのアナリストのコンセンサス予想に基づく収益と利益の成長予測を提示する。しかし、Cordlife Group は十分な過去のデータを提供しておらず、アナリストの予測もないため、過去のデータを外挿したり、アナリストの予測を使用しても、その将来の収益を確実に算出することはできません。

シンプリー・ウォール・ストリートがカバーする企業の97%は過去の財務データを持っているため、これはかなり稀な状況です。

業績と収益の成長予測

SGX:P8A - アナリストの将来予測と過去の財務データ ( )SGD Millions
日付	収益	収益	フリー・キャッシュフロー	営業活動によるキャッシュ	平均アナリスト数
12/31/2023	56	4	7	10	N/A
9/30/2023	56	4	8	11	N/A
6/30/2023	57	5	7	10	N/A
3/31/2023	56	5	5	8	N/A
12/31/2022	55	5	5	8	N/A
9/30/2022	55	5	5	7	N/A
6/30/2022	56	6	5	6	N/A
3/31/2022	56	6	6	8	N/A
12/31/2021	57	6	8	10	N/A
9/30/2021	58	6	10	12	N/A
6/30/2021	60	6	12	14	N/A
3/31/2021	60	6	13	15	N/A
12/31/2020	59	7	15	16	N/A
9/30/2020	59	8	14	15	N/A
6/30/2020	58	7	12	14	N/A
3/31/2020	58	7	10	12	N/A
12/31/2019	62	6	10	12	N/A
9/30/2019	60	3	7	8	N/A
6/30/2019	59	2	4	5	N/A
3/31/2019	69	4	5	6	N/A
12/31/2018	60	2	5	7	N/A
6/30/2018	68	3	7	9	N/A
3/31/2018	67	3	7	8	N/A
12/31/2017	62	-1	3	5	N/A
9/30/2017	62	-1	N/A	4	N/A
6/30/2017	60	-3	N/A	4	N/A
3/31/2017	60	-6	N/A	0	N/A
12/31/2016	60	-7	N/A	0	N/A
9/30/2016	60	4	N/A	-1	N/A
6/30/2016	60	12	N/A	-4	N/A
3/31/2016	60	36	N/A	-3	N/A
12/31/2015	59	56	N/A	-4	N/A
9/30/2015	59	43	N/A	-5	N/A
6/30/2015	58	32	N/A	-3	N/A
3/31/2015	56	28	N/A	0	N/A
12/31/2014	53	11	N/A	1	N/A
9/30/2014	51	18	N/A	4	N/A
6/30/2014	49	31	N/A	4	N/A
3/31/2014	45	18	N/A	3	N/A
12/31/2013	40	18	N/A	4	N/A
9/30/2013	37	19	N/A	6	N/A

アナリストによる今後の成長予測

収入対貯蓄率: P8Aの予測収益成長が貯蓄率 ( 2.1% ) を上回っているかどうかを判断するにはデータが不十分です。

収益対市場: P8Aの収益がSG市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です

高成長収益: P8Aの収益が今後 3 年間で大幅に増加すると予想されるかどうかを判断するにはデータが不十分です。

収益対市場: P8Aの収益がSG市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。

高い収益成長: P8Aの収益が年間20%よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。

一株当たり利益成長率予想

将来の株主資本利益率

将来のROE: P8Aの自己資本利益率が 3 年後に高くなると予測されるかどうかを判断するにはデータが不十分です

Cordlife Group 将来の成長

Future 基準チェック /06

主要情報

今後の成長に関する最新情報

Recent updates

High number of new and inexperienced directors

Cordlife Group Limited Announces Changes to the Composition of Board and the Board Composition

Cordlife Group Limited Announces Retirement of Cheong Tuck Yan Titus Jim as Independent Director

Cordlife Group Limited Announces the Appointment of Dato' Dr. Teo Tong Kooi as Independent Non-Executive Director, Effective May 14, 2024

Cordlife Group Limited Announces Directors Removal

Cordlife Group Limited (SGX:P8A) Looks Inexpensive After Falling 30% But Perhaps Not Attractive Enough

Cordlife Group Limited Announces Board Changes

Cordlife Group Limited Announces Board Resignations

New minor risk - Share price stability

Cordlife Group Limited has filed a Follow-on Equity Offering in the amount of SGD 8.191276 million.

Cordlife Group Limited has filed a Follow-on Equity Offering in the amount of SGD 8.191276 million.

Risks Still Elevated At These Prices As Cordlife Group Limited (SGX:P8A) Shares Dive 31%

New minor risk - Financial data availability

Full year 2023 earnings released: EPS: S$0.015 (vs S$0.019 in FY 2022)

Cordlife Group Limited Announces Changes in the Composition of the Board and Board Committees

New minor risk - Financial data availability

Cordlife Group Limited Announces the Cessation of Tan Poh Lan as Executive Director

Now 34% undervalued after recent price drop

Cordlife Group Limited Announces Resignation of Ms. Tan Poh Lan as a Group Chief Executive Officer, Effective 31 March 2024

Estimating The Fair Value Of Cordlife Group Limited (SGX:P8A)

New minor risk - Earnings quality

First half 2023 earnings released: EPS: S$0.009 (vs S$0.007 in 1H 2022)

Cordlife Group (SGX:P8A) Will Be Hoping To Turn Its Returns On Capital Around

New minor risk - Market cap size

Cordlife Group Limited Announces Change of Company Secretary

Cordlife Group Limited Announces Resignation of Kuan Yoke Kay as the Joint Company Secretary

Full year 2022 earnings released: EPS: S$0.019 (vs S$0.024 in FY 2021)

Cordlife Group (SGX:P8A) Might Be Having Difficulty Using Its Capital Effectively

Full year 2022 earnings released: EPS: S$0.019 (vs S$0.024 in FY 2021)

Now 20% undervalued after recent price drop

Cordlife Group Limited Appoints that Hnin Yi as Group Chief Financial Officer

Now 20% undervalued after recent price drop

Now 28% undervalued after recent price drop

High number of new directors

Cordlife Group Limited to Report Q1, 2023 Results on Nov 24, 2022

Cordlife Group (SGX:P8A) Is Looking To Continue Growing Its Returns On Capital

Cordlife Group Limited Announces Resignation of Choo Boon Yong as Group Chief Financial Officer

High number of new directors

Cordlife Group Limited Approves Final Tax Exempt (1-Tier) Dividend for the Financial Year Ended 31 December 2021

High number of new directors

Full year 2021 earnings: EPS exceeds analyst expectations while revenues lag behind

Cordlife Group Limited Proposes Final Tax Exempt Dividend for the Year Ended December 31, 2021, Payable on May 27, 2022

Full year 2021 earnings: EPS exceeds analyst expectations while revenues lag behind

Cordlife Group Limited Appoints Kuan Yoke Kay as the Joint Company Secretary

High number of new directors

Non-Independent Non-Executive Director Lin Wang has left the company

Cordlife Group's (SGX:P8A) Problems Go Beyond Weak Profit

Cordlife Group Limited Approves Final Dividend for the Financial Year Ended 31 December 2020, Payable on 28 May 2021

Cordlife Group Limited Announces the Launch of OptiQ

Global Cord Blood Corporation (NYSE:CO) cancelled the acquisition of Cordlife Group Limited (SGX:P8A) in a reverse merger transaction.

New 90-day high: S$0.40

Cordlife Group Limited Announces Resignation of Goh Jin Hian from the Position of Independent Director

First half earnings released

New 90-day high - S$0.40

業績と収益の成長予測

アナリストによる今後の成長予測

一株当たり利益成長率予想

将来の株主資本利益率

成長企業の発掘